Descriptive aspects of odontoma: literature review
Revista Odontológica Mexicana · 2016-10 · 20 (4) · e265-e269
DOI: 10.1016/j.rodmex.2016.11.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Odontológica Mexicana, 2016-10. Verfasst von Lucía Thistle Barba und 4 weiteren Autor:innen. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Odontoma is the most commonly found odontogenic tumor (35-76%). Odontoma is a benign tumor originating from an alteration of differentiated mesenchymal and epithelial odontogenic cells; it has the capacity of forming enamel, dentin and cement. They are classified into compound and complex, in a 2:1 relationship, the difference between both being dental tissue organization.Etiology is still unknown but relation to infections, hereditaryanomalies, odontoblastic hyperactivity and trauma has beenexplored. Since these tumors are asymptomatic, 75% of all cases are diagnosed before the second decade of life, due to a delay in eruption of permanent teeth. Treatment of choice for these tumors is enucleation, attempting to preserve the tooth; relapse is very uncommon.
Zitieren
APA
Barba, L. T., Campos, D. M., Rascón, M. M. N., Barrera, V. A. R., & Rascón, A. N. (2016). Descriptive aspects of odontoma: literature review. Revista Odontológica Mexicana, 20(4), e265-e269. https://doi.org/10.1016/j.rodmex.2016.11.018
Vancouver
Barba LT, Campos DM, Rascón MMN, Barrera VAR, Rascón AN. Descriptive aspects of odontoma: literature review. Revista Odontológica Mexicana. 2016;20(4):e265-e269. doi:10.1016/j.rodmex.2016.11.018
BibTeX
@article{Barba2016,
author = {Barba, Lucía Thistle and Campos, Daniela Muela and Rascón, Martina M Nevárez and Barrera, Víctor A Ríos and Rascón, Alfredo Nevárez},
title = {Descriptive aspects of odontoma: literature review},
journal = {Revista Odontológica Mexicana},
year = {2016},
volume = {20},
number = {4},
pages = {e265--e269},
doi = {10.1016/j.rodmex.2016.11.018}
}
EUVIMED